Allergy Therapeutics PLC
OTC:AGYTF

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
OTC:AGYTF
Watchlist
Price: 0.11 USD Market Closed
Market Cap: 524.3m USD

Wall Street
Price Targets

AGYTF Price Targets Summary
Allergy Therapeutics PLC

Wall Street analysts forecast AGYTF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGYTF is 0.13 USD with a low forecast of 0.13 USD and a high forecast of 0.13 USD.

Lowest
Price Target
0.13 USD
17% Upside
Average
Price Target
0.13 USD
18% Upside
Highest
Price Target
0.13 USD
21% Upside
Allergy Therapeutics PLC Competitors:
Price Targets
NOVN
Novartis AG
0% Upside
CLN
Celon Pharma SA
35% Upside
SUPRIYA
Supriya Lifescience Ltd
17% Upside
ETON
Eton Pharmaceuticals Inc
82% Upside
000513
Livzon Pharmaceutical Group Inc
28% Upside
ROVI
Laboratorios Farmaceuticos ROVI SA
34% Upside
AZN
AstraZeneca PLC
7% Upside

Revenue
Forecast

Revenue Estimate
Allergy Therapeutics PLC

For the last 13 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 2%. The projected CAGR for the next 1 year is 27%.

2%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Allergy Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGYTF's stock price target?
Price Target
0.13 USD

According to Wall Street analysts, the average 1-year price target for AGYTF is 0.13 USD with a low forecast of 0.13 USD and a high forecast of 0.13 USD.

What is Allergy Therapeutics PLC's Revenue forecast?
Projected CAGR
27%

For the last 13 years the compound annual growth rate for Allergy Therapeutics PLC's revenue is 2%. The projected CAGR for the next 1 year is 27%.

Back to Top